# Study of Oral Ridaforolimus in Combination With Standard Chemotherapy for Soft Tissue Sarcoma

> **NCT01296659** · PHASE1 · WITHDRAWN · sponsor: **The University of Texas Health Science Center at San Antonio**

## Conditions studied

- Soft Tissue Sarcoma

## Interventions

- **DRUG:** ridaforolimus

## Key facts

- **NCT ID:** NCT01296659
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-02
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Principal Investigator left institution.
- **Last updated:** 2012-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01296659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01296659, "Study of Oral Ridaforolimus in Combination With Standard Chemotherapy for Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01296659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*